nAture medicine RNA splicing, involving the spliceosome and the dynamic interaction of RNA and protein complexes 1 , is tightly regulated by proteins that repress or activate splice site selection. Among these are serine/arginine-domain-containing (SR) proteins and SR-related factors, which modulate the binding and assembly of the spliceosome complex and thereby determine the differential inclusion of exons in the mature transcript 2 . Few mutations in spliceosome components have been described, suggesting that the defects resulting from these mutations are incompatible with life 3 , and only a relatively small number of human diseases have been attributed to the trans effects of mutations in RNA binding proteins, including cancer, neurological diseases and muscular atrophy 4 . Nevertheless, mutations affecting splice consensus sites (cis effects) cause a wide range of disorders, including cardiac disease 5 .
RNA splicing, involving the spliceosome and the dynamic interaction of RNA and protein complexes 1 , is tightly regulated by proteins that repress or activate splice site selection. Among these are serine/arginine-domain-containing (SR) proteins and SR-related factors, which modulate the binding and assembly of the spliceosome complex and thereby determine the differential inclusion of exons in the mature transcript 2 . Few mutations in spliceosome components have been described, suggesting that the defects resulting from these mutations are incompatible with life 3 , and only a relatively small number of human diseases have been attributed to the trans effects of mutations in RNA binding proteins, including cancer, neurological diseases and muscular atrophy 4 . Nevertheless, mutations affecting splice consensus sites (cis effects) cause a wide range of disorders, including cardiac disease 5 .
Changes in gene and isoform expression are relevant to both adaptive effects of cardiac physiology and to cardiac disease-among them alternative splicing of the mRNA encoding the giant protein titin. Titin is a sarcomeric protein that determines the structure and biomechanical properties of striated muscle, and it has been associated with human cardiac disease 6 . Both alternative splicing [7] [8] [9] [10] and posttranslational modification tune titin-based passive tension, a key contributor to efficient ventricular filling 11, 12 . Titin phosphorylation in response to adrenergic stimulation has been attributed to the action of protein kinase A on the elastic N2B region 11 . Despite established links between the alternative splicing of titin and both thyroid hormone signaling and insulin signaling [13] [14] [15] , the splice factors that determine titin isoform transitions are unknown.
Here we studied a spontaneously occurring rat strain deficient in titin splicing that results in persistent expression of a giant titin isoform (N2BA-G) in adult cardiac tissue 16 . We used genome-wide mapping approaches to identify mutation of Rbm20 as the underlying cause for dysregulated titin splicing. Notably, human RBM20 has recently been linked to human dilated cardiomyopathy (DCM) and has been speculated to affect splicing 17, 18 . However, the function, regulation and substrates of RBM20 are unknown. We show that Rbm20 deficiency in rats leads to many phenotypic features that are observed in individuals with cardiomyopathy related to mutant RBM20, suggesting conserved RBM20 function. We then studied the function of RBM20 as a global regulator of cardiac alternative splicing and document considerable overlap of post-transcriptionally regulated genes that depend on RBM20. Our studies not only offer mechanistic insights but also provide functional annotation of RBM20 substrates that contribute to cardiomyopathy and heart failure, a major source of mortality in the developed world.
RESULTS

Identification of Rbm20 as an effector of titin isoforms
We used a backcross between rats deficient in titin splicing 16, 19 and the Brown Norway reference rat and identified a ~2-Mb interval on chromosome 1q55 that contains nine genes ( Fig. 1a and Supplementary  Fig. 1 ). Sequence analysis of the coding regions of these genes showed that only the Rbm20 gene differed between rats with and without the splicing deficiency: a 95-kb deletion removing exons 2-14 was associated with the splicing deficiency. These exons encode the RNA binding motif domain, arginine/serine-rich (RS) domain and Zn 2+ finger domain of the protein. We confirmed deletion of these exons by Southern blot, quantitative RT-PCR (qRT-PCR), and western blot analyses in rats heterozygous or homozygous for the Rbm20 deletion ( Fig. 1b-d) . In addition, we genotyped the Rbm20 deletion in all 191 rats from two independent backcrosses and found complete cosegregation between the titin splice defect and the presence of the Rbm20 deletion (Supplementary Fig. 1a) .
We then used adenoviral gene delivery to re-express Rbm20 in Rbm20-deficient rat cardiomyocytes and reconstituted expression of the short titin isoform (Fig. 1e-g ). The combination of rodent genetics and the reversion of the splice-deficient phenotype establishes Rbm20 as a trans-acting factor regulating titin isoform expression.
RBM20 regulates alternative splicing in striated muscle
We next investigated the function of RBM20 in alternative splicing. In the nuclei of mouse atrial myocyte HL-1 cells, Rbm20 partially colocalized with the splice factors Ptbp1 (polypyrimidine tract binding protein 1) and U2AF65 (U2 small nuclear RNA auxiliary factor 65-kDa subunit) (Fig. 2a) . The latter protein contains an RS domain that mediates its recruitment to sites of active splicing 20 . Using crosslinking and immunoprecipitation experiments, we found that Rbm20 binds total RNA (Fig. 2b) . Moreover, we confirmed the specific activity of Rbm20 on titin RNA using a splice reporter assay in which exclusion of the titin exon PEVK8, which contributes to titin's elasticity, results in reduced reporter activity (Fig. 2c) . In both mouse myoblasts (C2C12 cells) and human fibroblasts (HEK293 cells), expression of RBM20 led to the exclusion of the PEVK exon 8, which contains the firefly luciferase reporter ( Fig. 2d and Supplementary Fig. 2 ), and the assay was validated at the RNA level (Supplementary Fig. 2 ). Thus, Rbm20 is sufficient to drive the alternative splicing of titin's PEVK region in muscle and non-muscle cells, and this splicing evidently does not rely on a cardiac-specific cofactor. Expression of either of the splicing factors PTBP1 or HuD (ELAV-like 4) 21, 22 did not result in this splicing event, excluding nonspecific effects of RNA binding proteins (Fig. 2e) . Rbm20 promoted splicing in a dose-dependent fashion (Fig. 2f) .
Rbm20 is predominantly expressed in striated muscle, with highest expression in the heart (Fig. 2g) . In differentiating myoblasts, Rbm20 expression correlated with sarcomere assembly (Fig. 2h) : expression peaked when α-actinin was localized mainly in mature Z bodies within the nascent myofiber (punctuate α-actinin staining) and expression declined as the sarcomeres continued to mature (Fig. 2i) . Experimental cardiomyopathies in mice-both genetic and viral-did not affect Rbm20 expression (Supplementary Fig. 3 ).
Rats and humans share RBM20-dependent pathology Adult rats heterozygous or homozygous for the Rbm20-null allele had left ventricular dilatation as determined by echocardiography. Although left ventricular diastolic diameters were significantly larger in these rats compared to wild-type rats, there were no differences in the systolic ventricular dimensions or contractility indices, including fractional shortening, between any of the groups (Fig. 3a,b) .
In Rbm20-null heterozygous or homozygous rats, subendocardial fibrosis increased with age and was accompanied by electrical abnormalities, such as widening of the QRS complex, atrioventricular conduction delay and a predisposition to arrhythmia (Fig. 3c-f and Supplementary Figs. 4-6 ). Rbm20-deficient rats experienced sudden death (Fig. 3f) , similar to humans with RBM20 mutations who can experience sudden death well after adolescence 17, 18 . Thus, Rbm20-deficient rats mirror the pathological features of RBM20-deficient humans 17, 18 (Supplementary Table 1 ). Figure 1 Mapping of the titin splice defect and validation of RBM20 as the affected gene. (a) As depicted in schematic diagrams, in a titin splicedeficient rat strain, the quantitative trait locus resided in a 2.1-Mb interval on the long arm of chromosome 1 (1q55). The coding sequences of all known genes in the interval were unchanged, with the exception of the Rbm20 gene, which contained a 95 kb-deletion that eliminated all exons following exon 1. The endpoints of the deletion are shown in the 5′ and 3′ breakpoint (light and dark blue, respectively). UTR, untranslated region. (b) Southern blot of genomic DNA confirming the deletion with the loss of a 3-kb internal HindIII fragment in rats homozygous for the Rbm20 deletion (−/−) and a reduced amount of this fragment in rats heterozygous for the deletion (+/−) compared to wild-type (+/+) rats. (c) Rbm20 mRNA levels normalized to 18S ribosomal RNA and wild-type RNA levels, with a 76% reduction of Rbm20 RNA expression in heterozygous rats and no (<1%) Rbm20 RNA expression in homozygous rats. n = 3 rats per group. **P < 0.01, ***P < 0.001 (one-way analysis of variance (ANOVA)). Data are means ± s.e.m. (d) N2B titin isoforms in the indicated groups of rats, as determined by agarose gel electrophoresis. T2 refers to a proteolytic fragment of titin. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as a loading control. (e) Rbm20 expression in rat neonatal cardiomyocytes of the indicated genotypes after infection with Rbm20-expressing (+) or control (−) adenovirus. Ad-Rbm20, Rbm20-expressing adenovirus. (f) N2B titin isoforms in neonatal RBM20-deficient cardiomyocytes with Rbm20 (+) or control (C) adenovirus at the indicated time after adenoviral infection. Untransfected neonatal cardiomyocytes of the indicated genotypes were also analyzed. The asterisks indicate upregulation of the N2B isoform after Ad-Rbm20 infection. (g) Quantification of titin isoform expression as indicated in f, based on three rats per group. ***P < 0.001 by one-way ANOVA. Data are means ± s.e.m.
Titin splicing in a patient with a novel RBM20 mutation To validate RBM20-dependent titin splicing and its relevance in human disease, we investigated an individual with a heterozygous mutation in RBM20 resulting in a S635A amino acid substitution. The affected amino acid residue resides in an RS domain within an evolutionary highly conserved region of the protein (Fig. 4a,b) . This 34-year-old subject suffered from severe cardiomyopathy and had a clinical presentation that matched recently published patient data 17, 18 . We tested (g) Rbm20 protein expression in the indicated tissues of rats at 2 months of age. H, heart; Q, quadriceps; Ut, uterus; Thy, thymus; Lu, lung; Liv, liver; Kid, kidney; Spl, spleen; Br, brain; MW, molecular weight. Actin was used as a loading control. (h) C2C12 cells stained for α-actinin (red) as a marker of sarcomere maturation and staged for low, medium and high differentiation based on the fluorescence pattern. Rbm20 expression (green) was restricted to nuclei (DAPI, blue). Scale bar, 5 µm. Arrowheads point to nuclei. (i) Quantification of Rbm20 expression in undifferentiated C2C12 cells (−) and in cells at low, medium and high states of differentiation, as shown in h. The pixel sum is a measure of the combined signal intesity over the nuclear area. *P = 0.05, ***P < 0.001. One-way ANOVA; n > 15 cells per group. All data are means ± s.e.m. *** *** *** * *** 3,000 alleles from individuals without cardiomyopathy (who were ethnically matched to the affected individual) as controls and were unable to detect this variant; in addition, the S635A variant has not been reported in the dbSNP database or by the 1000 Genomes Project, indicating that it is not a frequent polymorphism. We used the splice reporter assay to test whether the newly identified S635A variant and all other known human RBM20 variants 17, 18 have functional effects. All of the variants analyzed showed a complete loss of function with the exception of the conserved amino acid change V535I, which is caused by the only identified mutation not within exon 9 (Fig. 4c,d) .
We next tested cardiac biopsy material from the individual with the S635A variant, as well as cardiac tissue from two subjects with TTN  CAMK2D  LDB3  TRDN  SEMA6D  NFIA  SPEN  CAMK2G  FHOD3  SORBS1  ZNF451  SH3KBP1  CACNA1C  KALRN  PDLIM5  DTNA  PLEKHA5  DAB1  FNBP1  SLC38A10  NPRL3  NTRK3  DNM3  GIT2  MECP2  APTX  KCNIP2  RALGPS1  MTMR1  TPM1 (b) Alternative splicing of genes identified by the RNA sequencing analysis as having high ∆PSI values was tested by RT-PCR analysis using cardiac mRNA from rats of the indicated RBM20 genotypes. i1, isoforms expressed at higher levels in wild-type rats than in mutant rats; i2, isoforms expressed at higher levels in mutant rats than in wild-type rats. Rbm20 exon 1 (5′) and exons 6 and 7 (3′) were amplified as controls; only the 5′ exon was present in the homozygous mutant. PCR fragments were sequence verified, as indicated in Supplementary Figure 9 . Trdn, triadin; Sorbs1, sorbin and SH3 domain containing 1; Sh3kbp1, SH3-domain kinase binding protein 1.
(c) Relative exon expression as determined by qRT-PCR using cardiac mRNA from rats of the indicated RBM20 genotypes. The regulation of LDB3 is opposite of all other genes tested with reduced inclusion of the alternative exon in homozygotes (−/−). The primers used are listed in Supplementary Figure 8 . *P ≤ 0.05, ***P ≤ 0.001, one-way ANOVA. n = 3 rats per group. All data are means ± s.e.m.
cardiomyopathy after cardiac transplantation who did not carry any mutations causing nonsynonymous amino acid changes in RBM20 (as determined by Sanger sequencing of the entire coding region). The individual with the heterozygous RBM20 mutation had a shift in titin isoform expression, with a higher-molecular-weight titin isoform compared to the isoform present in the controls (Fig. 4e) . This result is consistent with the rat studies, in which the larger titin isoform is expressed in heterozygous mutant rats (Fig. 4e) . The two control subjects expressed the N2B and N2BA titin isoforms of lower molecular weight, similar to the pattern found in healthy individuals (Fig. 4e) .
RBM20 regulates select genes related to cardiac disease
We used deep sequencing of the rat and human cardiac transcriptomes to refine our analysis of RBM20-dependent splicing. High-throughput RNA sequencing generates information at both the gene and the exon level, facilitating the identification of additional candidate substrates, as well as the exon composition of RBM20-dependent isoforms. We analyzed the cardiac transcriptomes of wild-type rats and rats either homozygous or heterozygous for the Rbm20-null allele (n = 3 rats per group) and compared them to the transcriptomes of humans with DCM with and without mutations in RBM20. We used cardiac tissue from relatively young rats (2 months of age), before the onset of cardiomyopathy, to minimize any potential secondary effects of cardiomyopathy on alternative splicing that are not dependent on RBM20. We generated ~150 million sequencing reads per sample (100-bp pairedend reads; Supplementary Fig. 7 ) and found 31 genes with shared RBM20-genotype-dependent splicing between rats and humans (false discovery rate <5%), which is a significantly greater overlap than would be expected by chance (P < 10 −5 ). This RBM20-dependent gene network includes TTN, whose alternative splicing was expected based on our initial experiments and, thus, validated our approach. We further confirmed the RNA sequencing results by RT-PCR and qRT-PCR for TTN and for six additional genes ( Fig. 5 and Supplementary Fig. 8) .
A Gene Ontology analysis of the RBM20-driven network showed enrichment for genes encoding proteins involved in sarcomere organization and ion transport in the sarcoplasmic reticulum (Fig. 5,  Supplementary Tables 2-5 and Supplementary Fig. 9 ). The 31 genes showed additional enrichment for the NCBI Medical Subject Headings (MeSH) 'heart failure' and 'cardiomyopathy' (Fig. 5 and Supplementary Table 6 ).
Several genes with RBM20-dependent isoform expression showed identical splicing patterns on the exon level across species (Fig. 6) . Ttn, Camk2d, Ldb3 and Cacna1c showed conserved differential splicing of orthologous exons between rat and human for the majority of their alternatively spliced exons (Figs. 5 and 6) . Of these four genes, Ttn was the most extensively mis-spliced in rats and humans: long stretches of exons were affected, the majority of which were overrepresented in RBM20 deficiency. This result is consistent with the expression of larger titin protein isoforms in both Rbm20-deficient rats and the human subject with the RBM20 S635A variant (Figs. 4 and 6) . The alternatively spliced exons reside in the elastic PEVK-and the immunoglobulin-rich region within the I band, which may help explain the increased distensibility of Rbm20-deficient sarcomeres 16 . undergoes an analogous exon switch that affects exon 4 (included in the control individuals and wild-type rats and exons 5 and 6 (included in the S635A human and Rbm20 mutant rats). (d) CACNA1C shows a conserved splicing pattern in human and rat for the majority of its alternatively spliced exons (8, 9* (an alternative exon 9 that can replace the standard exon 9), 22 and 31), but the RBM20-dependent differences in inclusion rates were small, with ∆PSI < 10. n = 3 rats per genotype. To show direct binding of RBM20 to its target splice sites, we focused on the 5′ splice site at the start of titin's alternatively spliced I-band region. Using a retention assay, we were able to complement our crosslinkingand immunoprecipitation-derived RNA-binding data regarding the interaction of RBM20 and titin RNA: titin mRNA corresponding to a 5′ exon-intron junction that precedes an alternatively spliced I-band region interacts with a glutathione-S-transferase (GST)-RRM fusion protein containing the RNA recognition motif of RBM20, but not with the GST protein negative control (Supplementary Fig. 10) .
For calcium/calmodulin-dependent protein kinase II δ (CaMKII-δ), RBM20 mutation resulted in splicing out of exon 14 and the inclusion of exons 15 and 16 (Fig. 6b) . This caused an isoform shift from CaMKII-δB to CaMKII-δA. It should be noted that exon 14 of CaMKII-δ contains its nuclear localization signal. A similar shift has been described in serine/arginine-rich splicing factor 1 (ASF, also called SF2)-deficient mice with altered excitation contraction coupling that leads to cardiac hypercontractility 23 . For the protein LDB3 (LIM domain binding 3), inclusion of exon 4 or exons 5 and 6 was mutually exclusive, and this differential inclusion was regulated by RBM20. Expression of exon 4 was downregulated in left ventricular tissue from Rbm20-deficient rats and in the individual with the RBM20 missense mutation (Fig. 6b) . For the calcium channel subunit Cacna1c (the α1C subunit of the L-type calcium channel), differential isoform expression has previously been related to arrhythmia 24 . We found that RBM20 mutation resulted in conserved changes in exon inclusion in this protein, although with smaller effects compared to the other three genes. This was assessed by the change in percentage spliced in (PSI) levels (Fig. 6d) . Finally, rat RNA-Seq data validated the deletion of RBM20 exons, as only exon 1 was expressed at similar levels in wild-type and Rbm20-deficient (Supplementary Fig. 11) . Furthermore, the intermediate levels in heterozygotes suggest the faithful representation of changes at the exon level in the RNA-Seq data set. DISCUSSION RBM20 has recently been linked to human cardiac disease, with RBM20 mutations present in 1.9-3% of individuals with idiopathic DCM 17, 18 , but the underlying mechanisms by which RBM20 mutation causes pathology have been unclear. Our analysis of RBM20 function in vivo and at the molecular level helps resolve this issue and shows that it regulates cardiac isoform expression. Rbm20-deficient rats and humans with RBM20 missense mutations both have cardiomyopathy with fibrosis and arrhythmia with sudden death. Our genome-wide transcriptomic analysis revealed a set of 31 RBM20-dependent genes, of which four (TTN, CAMK2D, LDB3 and CACNA1C) showed conserved regulation between rats and humans down to the exon level. As implied by the characterization of its substrate profile, which includes alternatively spliced genes encoding structural, sarcomeric, enzymatic and signaling proteins, RBM20 regulates the isoform expression of genes related to diastolic function, sarcomere assembly and ion transport.
We verified the transcriptomics data using several methods, including the confirmation of concordant protein isoform and RNA isoform expression of rat and human titin. Because of a lack of sufficient human biopsy material, we focused our validation of the RNA-Seq data on the rat. RT-PCR and qRT-PCR analyses confirmed the differential isoform expression of 7 of the 14 genes that were identified as differentially spliced by RNA-Seq with a ∆PSI >10% dependent on RBM20. Our deep sequencing analysis with long (100 bp) paired-end reads that span exon borders enabled the detection of even small changes in isoform regulation with a statistical significance that cannot be obtained using RT-PCR (∆PSI <10%; data not shown). Because RBM20-genotype-dependent isoform expression was consistent between species, we also considered genes with low ∆PSI values as part of the set of RBM20-regulated candidate genes.
Our analysis of titin-splice-deficient rats revealed a genomic deletion leading to a loss of function of the SR-related protein Rbm20. SR and SR-related proteins are highly conserved in metazoans 25 , and their modular structure, with one or two RNA recognition motifs and an RS domain, is essential for RNA and protein interactions and recruitment of the splicing machinery 26 . About half of the more than 100 SR-related proteins identified to date have been implicated in splicing 2 . Regulation of alternative splicing can be achieved by temporal and spatial control of the tissue-specific expression of RS proteins or by post-translational modification of these proteins. Similar to its largest substrate, titin, Rbm20 is predominantly expressed in striated muscle (in contrast to most SR-related proteins, which are ubiquitously expressed), and we found that its expression in differentiating myocytes peaks as their sarcomeric structure is being built. The difference in the calculated size of Rbm20 of ~130 kDa and its migration during gel electrophoresis at ~180 kDa implies that it is post-translationally modified. Indeed, SR-related proteins are frequently regulated by phosphorylation, resulting in a sizeable difference between the calculated and observed molecular weights for many of these proteins 27 . The phosphorylation of SR-related proteins has previously been associated with re-import into the nucleus 27 and the regulation of alternative splicing 28 . We found that Rbm20 is localized to the nucleus throughout myogenic differentiation and did not detect it in the cytoplasm. This would suggest a function for RBM20 in the major (nuclear) spliceosome.
The availability of rat and human cardiac tissue for analysis of RBM20-dependent isoform expression provided several leads toward understanding the mechanism underlying RBM20-related pathology. This analysis suggests that RBM20 has a crucial role in multiple aspects of cardiac function through effects on genes involved in biomechanics (TTN and TPM1), ion homeostasis and electrical activity (CAMK2D and CACNA1C) and signal transduction (CAMK2D and SPEN). Furthermore, in addition to differential splicing of titin 6 and CAMKII-δ 29 , changes in the isoform expression of LDB3 (also known as cypher) and CACNA1C have been shown to be related to dilated cardiomyopathy and arrhythmia, respectively 30, 31 .
Titin is a prominent target of RBM20, and TTN mutations are known to contribute to cardiomyopathy 6, 32 . Although altered titin splicing is frequently found in cardiovascular disease 7, [33] [34] [35] , previously reported changes in titin isoform expression are rather minor, unlike the effects of the RBM20 mutation, which leads to the production of extremely large N2BA isoforms. These isoforms are predicted to cause an increase in titin-based elasticity that has implications for diastolic function and the Frank-Starling mechanism 16 . Furthermore, the reduced recoil associated with a flaccid titin filament could lead to a compensatory increase in collagen biosynthesis and ultimately to fibrosis.
Calcium handling is a crucial component of cardiac function and is affected in all knockouts of cardiac splice factors described to date. Deficiency in either serine/arginine-rich splicing factor 2 (SC35) or serine/arginine-rich splicing factor 10 (SRp38) leads to altered Ca 2+ release from the sarcoplasmic reticulum with downregulation of the ryanodine receptor 2 (RyR2) 36 and defective splicing of TRDN (encoding triadin) 37 , respectively. As we also identified TRDN as a substrate of RBM20, both SRp38 and RBM20 seem to regulate splicing of this gene. Mutations in both SRSF1 (encoding ASF, also known as SF2) and RBM20 affect CAMKII-δ isoform expression. Mutations in either gene lead to the production of isoforms lacking a nuclear localization signal 23 . Such isoforms are mistargeted to the sarcolemma, causing not only excitation-contraction coupling defects 23 but also an increase in a propensity for ventricular tachycardia 38 , similar to the phenotype we observed in Rbm20-deficient rats.
Mutations in LDB3 have previously been implicated in dilated cardiomyopathy 39, 40 . Here we found that RBM20 mediates mutually exclusive inclusion of exon 4 or exons 5 and 6 of LDB3. Exon 4 of LDB3 has been implicated in binding to the glycolytic enzyme phosphoglucomutase 1 (PGM1), and mutations in exon 4 of LDB3 have been shown to associate with DCM through impaired binding of PGM1 (ref. 41 ). We here show exon 4 of LDB3 to be downregulated in cardiac tissue from Rbm20-deficient rats and from the human subject with a RBM20 missense mutation. This shift in LDB3 isoform expression would be expected to decrease the number of PGM1 binding sites, which could conceivably alter recruitment of the glycolytic enzyme PGM1 to the Z disk.
DCM is a leading cause of heart failure and cardiac transplantation in Western countries and has been extensively studied 42 . Although there is evidence of a substantial inherited contribution to DCM, and numerous causal genes for DCM have been identified, within affected families it is often the case that there is incomplete penetrance and a variable phenotype 43 , and the causal gene is known in only a small subset of such families. Among the genes identified are those encoding sarcomeric contractile proteins, cytoskeletal proteins, nuclear membrane proteins, and the dystrophin-associated glycoprotein complex 44 . Notably, although >15% of human genetic diseases have been attributed to mutations in cis-acting splice elements. RBM20 mutation is one of only a few examples of a trans-acting effect and establishes the regulation of alternative splicing as a hitherto unappreciated cause of cardiomyopathy 5, 45 .
In conclusion, our data suggest a model in which reduced activity of RBM20 results in altered isoform expression of proteins that maintain sarcomeric structure and cardiac function, among them titin, CAMKII-δ, LDB3 and CACNA1C. These changes may result in altered biomechanics, electrical activity and signal transduction that ultimately lead to cardiomyopathy, fibrosis, arrhythmia and sudden death. Our data highlight the key role of post-transcriptional regulation in physiological cardiac function and heart failure.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. Accession codes. All rat and human RNA sequencing data have been submitted to the Sequencing Read Archive of the European Nucleotide Archive (ERP001301, http://www.ebi.ac.uk/ena/data/ view/ERP001301). The GenBank accession numbers for human and rat RBM20 are EU822950 and EU562301, respectively.
Note: Supplementary information is available on the Nature Medicine website.
